Total mortality · patients with coronary heart disease
Internet‐based interventions showed no clear difference in total mortality compared with usual care or no care (low certainty).
1 finding from 1 review
Clinical CVD events (CVD mortality and non‐fatal MI) · people at high risk of or withcardiovascular disease
It is very uncertain whether mindfulness‐based interventions (MBIs) changes clinical CVD events (CVD mortality and non‐fatal MI) compared with non‐active comparators (very low certainty).
1 finding from 1 review
HF mortality · adults with heart failure
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
HF mortality · adults with heart failure
It is very uncertain whether multidisciplinary disease management programmes changes HF mortality compared with usual care (very low certainty).
1 finding from 1 review
HF mortality · adults with heart failure
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · adults with heart failure
Multidisciplinary disease management programmes probably leads to lower all‐cause mortality compared with usual care (moderate certainty).
1 finding from 1 review
All‐cause mortality · adults with heart failure
Case management may leads to lower all‐cause mortality compared with usual care (low certainty).
1 finding from 1 review
All‐cause mortality · adults with heart failure
Clinic‐based intervention showed no clear difference in all‐cause mortality compared with usual care (low certainty).
1 finding from 1 review
All‐cause mortality · heart failure in patients with Chagas cardiomyopathy
It is very uncertain whether carvedilol changes all‐cause mortality compared with placebo (very low certainty).
1 finding from 1 review
All‐cause mortality · chronic heart failure in Chagas cardiomyopathy patients
1 finding from 1 review
All‐cause mortality · participants with high risk of sudden cardiac death (secondary prevention)
Amiodarone showed no clear difference in all‐cause mortality compared with other antiarrhythmics (low certainty).
1 finding from 1 review
All‐cause mortality · participants with high risk of sudden cardiac death (secondary prevention)
It is very uncertain whether amiodarone changes all‐cause mortality compared with beta blockers (very low certainty).
1 finding from 1 review
All‐cause mortality · participants with high risk of sudden cardiac death (secondary prevention)
It is very uncertain whether amiodarone changes all‐cause mortality compared with sotalol (very low certainty).
1 finding from 1 review
All‐cause mortality · participants with high risk of sudden cardiac death (primary prevention)
Amiodarone showed no clear difference in all‐cause mortality compared with placebo or no treatment (low certainty).
1 finding from 1 review
All‐cause mortality · beta blockers
Amiodarone may leads to lower all‐cause mortality compared with beta blockers (low certainty).
1 finding from 1 review
All‐cause mortality · participants with high risk of sudden cardiac death (primary prevention)
Amiodarone probably leads to lower all‐cause mortality compared with other antiarrhythmics (moderate certainty).
1 finding from 1 review
All‐cause mortality · participants with high risk of sudden cardiac death (secondary prevention)
It is very uncertain whether amiodarone changes all‐cause mortality compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Total mortalityDeaths · patients with coronary heart disease
Psychological intervention with or without other rehabilitation showed no clear difference in total mortalityDeaths compared with control (usual care/other rehabilitation) (moderate certainty).
1 finding from 1 review
Cardiac mortalityDeaths · patients with coronary heart disease
Psychological intervention with or without other rehabilitation may leads to lower cardiac mortalityDeaths compared with control (usual care/other rehabilitation) (low certainty).
1 finding from 1 review
Cardiac mortality · heart failure in patients with Chagas cardiomyopathy
1 finding from 1 review